Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Divestments (2023 - 2024)

Creative Medical Technology Holdings (CELZ) has disclosed Divestments for 2 consecutive years, with $6.5 million as the latest value for Q1 2024.

  • Quarterly Divestments rose 29.44% to $6.5 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $6.5 million through Dec 2024, down 75.3% year-over-year, with the annual reading at $6.5 million for FY2024, 75.3% down from the prior year.
  • Divestments for Q1 2024 was $6.5 million at Creative Medical Technology Holdings, down from $17.4 million in the prior quarter.
  • The five-year high for Divestments was $17.4 million in Q4 2023, with the low at $11133.0 in Q2 2023.